FDA
Updated Covid vaccines need to target XBB omicron variants this fall, FDA staff says
Syringe with Covid-19 vaccine against the XBB Variant. Fight against virus Covid-19 Coronavirus, Vaccination and immunization. Undefined Undefined | Istock | Getty Images U.S. Food and Drug Administration staff on Monday said updated Covid boosters should target XBB omicron subvariants for the upcoming fall and winter vaccination campaign. The U.S. should use a monovalent vaccine […]
Read More
Stocks making the biggest moves midday: Nvidia, Tesla, Coinbase and more
In this article PARA IOVA COIN AI CHPT F TSLA NVDA XOM CVX FANG DVN Follow your favorite stocksCREATE FREE ACCOUNT Visitors at the Nvidia stand at the 2022 Apsara Conference in Hangzhou, China, Nov 3, 2022. Nvidia Stock Soar | Future Publishing | Getty Images Check out the companies making headlines in midday trading. […]
Read More
FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
The Food and Drug Administration on Thursday granted full approval to Pfizer’s Covid antiviral pill, Paxlovid, for adults who are at high risk of getting severely sick with the virus. Paxlovid is specifically advised for the treatment of mild to moderate Covid in adults older than 50 and people who suffer from certain medical conditions […]
Read More
Here’s what Pfizer and Moderna say is subsequent for their Covid vaccines
A pharmacist prepares to administer COVID-19 vaccine booster pictures through an function hosted by the Chicago Division of Public Health and fitness at the Southwest Senior Middle on September 09, 2022 in Chicago, Illinois. Scott Olson | Getty Pictures 3 several years and billions of Covid vaccinations into the pandemic, Pfizer and Moderna say their […]
Read More
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images The Food and Drug Administration’s independent panel of advisors on Thursday recommended full approval of Pfizer’s vaccine that protects infants from RSV, but raised safety concerns over premature births that may be tied to the shot. The committee unanimously said the […]
Read More
Pfizer RSV vaccine for infants has ‘generally favorable’ safety data, FDA staff say
Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Images U.S. Food and Drug Administration staff on Tuesday said Pfizer’s vaccine that protects infants from respiratory syncytial virus has “generally favorable” safety data. The FDA staff made the conclusion in briefing documents ahead of a meeting on Thursday, when a panel […]
Read More
FDA commissioner praises Eli Lilly Alzheimer’s treatment results
FDA Commissioner Dr. Robert Califf speaks at an event celebrating hearing aids being available over the counter at a Walgreens in Washington, D.C., Oct. 19, 2022. Nathan Posner | Anadolu Agency | Getty Images Food and Drug Commissioner Dr. Robert Califf praised results Eli Lilly announced Wednesday that a clinical trial showed its Alzheimer’s treatment […]
Read More
FDA approves GSK’s RSV vaccine for older adults, world’s first shot against virus
A GSK lab in London. Oli Scarff | Getty Images The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older. The approval, the first ever globally by a regulatory body for an RSV vaccine, is a decisive victory for GSK in a race […]
Read More
Alzheimer’s: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Chiquita Brooks-LaSure testifies before the Senate Finance Committee during her nomination hearing to be administrator of the Centers for Medicare & Medicaid Services in Washington on Thursday, April 15, 2021. Caroline Brehman | CQ-Roll Call, Inc. | Getty Images Medicare will cover the new Alzheimer’s treatment Leqembi for all patients eligible under the medication’s label […]
Read More
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration on Tuesday granted accelerated approval for Biogen‘s drug tofersen, which treats a rare and aggressive form of the disease known as ALS. Accelerated approval is an FDA designation […]
Read More